Cerus Endovascular Press Releases
Cerus Endovascular Announces IDE Approval from the U.S. FDA to Conduct Clinical Study of the Contour Neurovascular System™
21 April 2021
Cerus Endovascular Receives FDA Breakthrough Device Designation for its Contour Neurovascular System™
11 February 2021
Cerus Endovascular Announces the First Ever Robotic Assist Intracranial Implant of its Contour Intrasaccular Device
17 December 2020
Cerus Endovascular and Balt Enter Strategic Distribution Agreement for Innovative Neurovascular Devices to Treat a Range of Intracranial Aneurysms
4 August 2020
Cerus Endovascular Receives CE Mark Approval for its Contour 021 device
27 July 2020
Cerus Endovascular Receives CE Mark Approval for its
Contour 021
29 April 2020
View or download Press Release
Cerus Endovascular Receives CE Mark Approvals for its Neqstent™ Coil Assisted Flow Diverter Designed to Treat Intracranial Aneurysms
22 April 2020
View or download Press Release
Cerus Endovascular Successfully Completes Series B Financing and Receives U.S. FDA Approval for its First Microcatheter
21 February 2020
View or download Press Release
Cerus Endovascular Expands Intellectual Property Portfolio Brings Patent Portfolio
to Five Issued U.S. Patents and over 20+ Pending Patent Applications
27 November 2018
Cerus Endovascular Enrolls First Patients in CERUS Study to Treat Intra-Cranial Aneurysms Using Contour Neurovascular System™ to Reduce the Risk of Rupture
13 November, 2018
Cerus Endovascular Strengthens Board of Directors with Appointment of John T. Kilcoyne
18 September, 2018
Cerus Endovascular Promotes Stephen Griffin, PhD, to President:
Company On-Track to Achieve Key Clinical and Regulatory Milestones
11 May, 2018
Cerus Endovascular Provides Corporate Update:
Controlled commercial roll-out of the Contour Neurovascular System™ progressing, with 25 key sites confirmed Highly successful first-in-man implantation of the NEQSTENT™ Intra-Saccular Stent completed, with additional cases anticipated
7 September, 2017
Cerus Endovascular Receives CE Mark Approval for its
Contour Neurovascular System™, Designed to Treat Intracranial Aneurysms
18 February 2020
View or download Press Release
View or download Press Release
View or download Press Release
View or download Press Release
View or download Press Release
View or download Press Release